n-benzyloxycarbonylprolylprolinal has been researched along with (2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole in 4 studies
| Studies (n-benzyloxycarbonylprolylprolinal) | Trials (n-benzyloxycarbonylprolylprolinal) | Recent Studies (post-2010) (n-benzyloxycarbonylprolylprolinal) | Studies ((2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole) | Trials ((2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole) | Recent Studies (post-2010) ((2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole) |
|---|---|---|---|---|---|
| 39 | 0 | 7 | 22 | 2 | 9 |
| Protein | Taxonomy | n-benzyloxycarbonylprolylprolinal (IC50) | (2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole (IC50) |
|---|---|---|---|
| Prolyl endopeptidase | Homo sapiens (human) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerber-Lemaire, S; Juillerat-Jeanneret, L; Lawandi, J; Moitessier, N | 1 |
| Airaghi, F; Auclair, K; De Cesco, S; Huskić, I; Kurian, J; Mariaule, G; Mittermaier, A; Moitessier, N; Rocheleau, S; Schiavini, P | 1 |
| Dufresne, C; Hédou, D; Labarre, A; Mittermaier, A; Moitessier, N; Plescia, J; Pousse, ME | 1 |
| Carretero, OA; Cavasin, MA; Rhaleb, NE; Yang, XP | 1 |
1 review(s) available for n-benzyloxycarbonylprolylprolinal and (2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole
| Article | Year |
|---|---|
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
Topics: Animals; Blood-Brain Barrier; Central Nervous System; Humans; Prolyl Oligopeptidases; Protein Binding; Serine Endopeptidases; Serine Proteinase Inhibitors | 2010 |
3 other study(ies) available for n-benzyloxycarbonylprolylprolinal and (2s,3as,7as)-1-(((r,r)-2-phenylcyclopropyl)carbonyl)-2-((thiazolidin-3-yl)carbonyl)octahydro-1h-indole
| Article | Year |
|---|---|
3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors.
Topics: Bridged Bicyclo Compounds; Carboxylic Acids; Humans; Isoindoles; Molecular Docking Simulation; Molecular Structure; Prolyl Oligopeptidases; Protease Inhibitors; Serine Endopeptidases; Stereoisomerism | 2016 |
Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
Topics: Endopeptidases; Enzyme Inhibitors; Humans; Membrane Proteins; Neoplasms; Prolyl Oligopeptidases; Serine Endopeptidases | 2022 |
Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Indoles; Kidney; Kidney Cortex; Male; Myocardium; Nitriles; Oligopeptides; Organ Specificity; Proline; Prolyl Oligopeptidases; Protease Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Thiazoles; Thiazolidines; Thymosin | 2004 |